3Spine, founded as a privately-held medical device company, is pioneering the first low back total joint replacement as an alternative to spinal fusion. Their core mission is to restore natural balance, maintain range of motion, and preserve adjacent spinal levels in patients with lumbar spine issues. The company's flagship product, MOTUS, replaces the function of the disc and facet joints, offering a significant advancement in spinal surgery. 3Spine aims to revolutionize the spinal surgery market by providing a more effective and less invasive solution compared to traditional spinal fusion.
Notable affiliated individuals and investors include leading orthopedic surgeons and venture capital firms specializing in medical technology. Key achievements for 3Spine include successful clinical trials and regulatory milestones that demonstrate the efficacy and safety of MOTUS. The overall impact of 3Spine's innovation is substantial, offering patients improved outcomes and quality of life while reducing the long-term complications associated with spinal fusion.
